The stock of Amsurg Incorporated (NASDAQ:AMSG) registered an increase of 39.52% in short interest. AMSG’s total short interest was 8.76M shares in September as published by FINRA. Its up 39.52% from 6.28M shares, reported previously. With 1.19M shares average volume, it will take short sellers 7 days to cover their AMSG’s short positions. The short interest to Amsurg Incorporated’s float is 16.68%. The stock decreased 3.16% or $2.19 during the last trading session, hitting $67.22. About 1.17M shares traded hands. Amsurg Corp (NASDAQ:AMSG) has risen 12.94% since February 8, 2016 and is uptrending. It has underperformed by 3.55% the S&P500.
AmSurg Corp. is a surgical center and physician services company. The company has a market cap of $3.76 billion. The Firm is an owner and operator of ambulatory surgery centers in the United States. It has a 21.34 P/E ratio. The Firm is also a well-known provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
The institutional sentiment decreased to 0.86 in 2016 Q2. Its down 0.13, from 0.99 in 2016Q1. The ratio is negative, as 29 funds sold all Amsurg Corp shares owned while 118 reduced positions. 39 funds bought stakes while 88 increased positions. They now own 52.50 million shares or 5.39% less from 55.50 million shares in 2016Q1.
Southernsun Asset Management Llc holds 2.32% of its portfolio in Amsurg Corp for 1.14 million shares. Eagle Boston Investment Management Inc owns 213,611 shares or 2.25% of their US portfolio. Moreover, Consolidated Investment Group Llc has 2.13% invested in the company for 54,384 shares. The Connecticut-based Scholtz & Company Llc has invested 1.97% in the stock. Capital Growth Management Lp, a Massachusetts-based fund reported 550,000 shares.
Out of 7 analysts covering AmSurg (NASDAQ:AMSG), 5 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 71% are positive. AmSurg has been the topic of 10 analyst reports since September 16, 2015 according to StockzIntelligence Inc. Mizuho maintained the stock on June 24 with “Buy” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.